These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 15972345)
1. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345 [TBL] [Abstract][Full Text] [Related]
2. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
4. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines. Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959 [TBL] [Abstract][Full Text] [Related]
5. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study. Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264 [TBL] [Abstract][Full Text] [Related]
6. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848 [TBL] [Abstract][Full Text] [Related]
7. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey. Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405 [TBL] [Abstract][Full Text] [Related]
8. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Dai C; Stafford RS; Alexander GC Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363 [TBL] [Abstract][Full Text] [Related]
9. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Sun SX; Lee KY; Bertram CT; Goldstein JL Curr Med Res Opin; 2007 Aug; 23(8):1859-66. PubMed ID: 17605893 [TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France. Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495 [TBL] [Abstract][Full Text] [Related]
11. Inadequate prevention of NSAID-induced gastrointestinal events. Herings RM; Goettsch WG Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416 [TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs. Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ; Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Lazzaroni M; Bianchi Porro G Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413 [TBL] [Abstract][Full Text] [Related]
14. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. van Leen MW; van der Eijk I; Schols JM Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740 [TBL] [Abstract][Full Text] [Related]
15. The prescribing and adverse reactions of nonsteroidal antiinflammatory drugs in general practice: a Dunedin study. Taylor D; Clark DW; Dovey SM; Tilyard MW N Z Med J; 1994 Jul; 107(981):263-6. PubMed ID: 8022581 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF; Hsiao FY; Wen YW; Tsai YW Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [TBL] [Abstract][Full Text] [Related]
17. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm). Vlahovic-Palcevski V; Wettermark B; Bergman U Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607 [TBL] [Abstract][Full Text] [Related]
18. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523 [TBL] [Abstract][Full Text] [Related]
19. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Joshua FF; Oakley SP; Major GA Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694 [TBL] [Abstract][Full Text] [Related]
20. Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Behan K; Cutts C; Tett SE J Clin Pharm Ther; 2005 Aug; 30(4):337-43. PubMed ID: 15985047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]